Reviewed profile

food and beverage brand · public preview

Kazano

Retail brand

Public category
Retail brand
Brand tier
challenger brand
Headquarters
United States
Is this your company?Claim Kazano to get found by buyers, add products and certifications, correct your details, and be eligible when Talio’s AI recommends suppliers.Let our AI make the introductionGet a warm, researched intro to Kazano — no cold outreach.
Report a changeLog in for full recordLast reviewed 11 Jun 2026 · public preview data

Overview

What Kazano covers.

Kazano is a prescription medication containing a combination of alogliptin and metformin hydrochloride. It is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. The drug is marketed by Takeda Pharmaceuticals America, Inc.

  • Positioned as a challenger brand.
  • Headquartered in United States.

FAQ

Questions this page answers.

What does Kazano do?

Kazano is a food and beverage brand based in United States, tracked in Talio's food and beverage intelligence platform.

Is this the full Talio record?

No. This page is a public preview; proprietary metrics and workflow features remain inside authenticated Talio.

Own this company?

Get found by buyers — and the AI that recommends suppliers.

Claim this profile to appear in buyer searches, add your products and certifications, correct outdated details, and stay eligible when Talio's AI recommends suppliers.

Claiming grants reviewed submission rights only — not direct editing, suppression, or ownership of Talio-derived intelligence. Verification required.

Claim this pageLog in for full recordReport a change

Public preview data only · proprietary metrics remain in authenticated Talio.